Cargando…

PREDICT: model for prediction of survival in localized prostate cancer

PURPOSE: Current models for prediction of prostate cancer-specific survival do not incorporate all present-day interventions. In the present study, a pre-treatment prediction model for patients with localized prostate cancer was developed. METHODS: From 1989 to 2008, 3383 patients were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerkmeijer, Linda G. W., Monninkhof, Evelyn M., van Oort, Inge M., van der Poel, Henk G., de Meerleer, Gert, van Vulpen, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879170/ https://www.ncbi.nlm.nih.gov/pubmed/26420595 http://dx.doi.org/10.1007/s00345-015-1691-4

Ejemplares similares

A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer
por: Hasannejadasl, Hajar, et al.
Publicado: (2023)

Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer
por: Hasannejadasl, Hajar, et al.
Publicado: (2023)

External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy
por: Veerman, Hans, et al.
Publicado: (2022)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020)

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018)

Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging
por: Meijer, Dennie, et al.
Publicado: (2021)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
por: van der Doelen, Maarten J., et al.
Publicado: (2021)

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy
por: Rybalov, Maxim, et al.
Publicado: (2014)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors
por: Wollersheim, Barbara M., et al.
Publicado: (2020)

Prostate MRI for Improving Personalized Risk Prediction of Incontinence and Surgical Planning: The Role of Membranous Urethral Length Measurements and the Use of 3D Models
por: Boellaard, Thierry N., et al.
Publicado: (2023)

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology
por: Hall, William A., et al.
Publicado: (2022)

Effectiveness and toxicity of conventional radiotherapy treatment for painful spinal metastases: a detailed course of side effects after opposing fields versus a single posterior field technique
por: Westhoff, Paulien G., et al.
Publicado: (2017)

Verrast
por: van der Poel, Henk G.
Publicado: (2020)

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients
por: EL-SAGHIRE, HOUSSEIN, et al.
Publicado: (2014)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
por: Hendriks, Rianne J., et al.
Publicado: (2018)

Parameters predicting [(18)F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy
por: Seyrek, Neslisah, et al.
Publicado: (2022)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression
por: Wollersheim, Barbara M., et al.
Publicado: (2019)

Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands
por: Cremers, Ruben, et al.
Publicado: (2011)

External Validation of Two Nomograms Developed for (68)Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer (18)F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?
por: Luiting, Henk B., et al.
Publicado: (2021)

Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
por: de Barros, Hilda A., et al.
Publicado: (2023)

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Comparison of Functional Outcome after Extended versus Super-Extended Pelvic Lymph Node Dissection during Radical Prostatectomy in High-Risk Localized Prostate Cancer
por: Seikkula, Heikki, et al.
Publicado: (2017)

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410
por: Veerman, Hans, et al.
Publicado: (2022)

The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study
por: Poelaert, Filip, et al.
Publicado: (2015)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer
por: van Oort, I. M., et al.
Publicado: (2008)

The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
por: Benoist, Guillemette E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pokvah7bidl9fk4e1vr3b3m8jc